loadpatents
Patent applications and USPTO patent grants for Yusuff; Naeem.The latest application filed is for "deuterated analogs of d-beta-hydroxybutyric acid and uses thereof".
Patent | Date |
---|---|
Deuterated Analogs Of D-beta-hydroxybutyric Acid And Uses Thereof App 20210008018 - Tung; Roger D. ;   et al. | 2021-01-14 |
Biaryl amide compounds as kinase inhibitors Grant 10,709,712 - Aversa , et al. | 2020-07-14 |
Biaryl Amide Compounds As Kinase Inhibitors App 20190175606 - AVERSA; Robert John ;   et al. | 2019-06-13 |
Biaryl amide compounds as kinase inhibitors Grant 10,245,267 - Aversa , et al. | 2019-04-02 |
Biaryl Amide Compounds As Kinase Inhibitors App 20170260207 - AVERSA; Robert John ;   et al. | 2017-09-14 |
Biaryl amide compounds as kinase inhibitors Grant 9,694,016 - Aversa , et al. July 4, 2 | 2017-07-04 |
Pyridazinyl derivatives as SMO inhibitors Grant 9,409,871 - He , et al. August 9, 2 | 2016-08-09 |
Biaryl Amide Compounds As Kinase Inhibitors App 20160038504 - AVERSA; Robert John ;   et al. | 2016-02-11 |
Biaryl amide compounds as kinase inhibitors Grant 9,242,969 - Barsanti , et al. January 26, 2 | 2016-01-26 |
Compounds for inhibiting the interaction of BCL2 with binding partners Grant 9,126,979 - Ford , et al. September 8, 2 | 2015-09-08 |
Compounds for inhibiting the interaction of BCL2 with binding partners Grant 9,126,980 - Visser , et al. September 8, 2 | 2015-09-08 |
Compounds For Inhibiting The Interaction Of Bcl2 With Binding Partners App 20150080428 - Visser; Michael Scott ;   et al. | 2015-03-19 |
Compounds For Inhibiting The Interaction Of Bcl2 With Binding Partners App 20140357666 - Visser; Michael Scott ;   et al. | 2014-12-04 |
Compounds For Inhibiting The Interaction Of Bcl2 With Binding Partners App 20140357633 - Ford; Daniel ;   et al. | 2014-12-04 |
Compounds For Inhibiting The Interaction Of Bcl2 With Binding Partners App 20140350014 - Ford; Daniel ;   et al. | 2014-11-27 |
Compounds For Inhibiting The Interaction Of Bcl2 With Binding Partners App 20140343093 - Ford; Daniel ;   et al. | 2014-11-20 |
Biaryl Amide Compounds As Kinase Inhibitors App 20140275003 - Barsanti; Paul A. ;   et al. | 2014-09-18 |
Sulfonamides as inhibitors of Bcl-2 family proteins for the treatments of cancer Grant 8,809,352 - Miller-Moslin , et al. August 19, 2 | 2014-08-19 |
Pyridazinyl Derivatives As Smo Inhibitors App 20130261299 - He; Feng ;   et al. | 2013-10-03 |
Benzyl and pyridinyl derivatives as modulators of the hedgehog signaling pathway Grant 8,536,168 - Dai , et al. September 17, 2 | 2013-09-17 |
Pyridazinyl derivatives as smo inhibitors Grant 8,481,542 - He , et al. July 9, 2 | 2013-07-09 |
Organic Compounds As Smo Inhibitors App 20120289507 - HE; Feng ;   et al. | 2012-11-15 |
Sulfonamide Compounds App 20120165298 - Miller-Moslin; Karen ;   et al. | 2012-06-28 |
Organic Compounds and Their Uses App 20100069368 - Dai; Miao ;   et al. | 2010-03-18 |
Organic Compounds as Smo Inhibitors App 20100041663 - HE; Feng ;   et al. | 2010-02-18 |
1,4-Disubstituted isoquinilone derivatives as raf-kinase inhibitors useful for the treatment of proliferative diseases App 20070060582 - Fink; Cynthia Anne ;   et al. | 2007-03-15 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.